Dowlais Group plc, the UK-based automotive specialist, continues to draw market maker disclosures under Form 8.5 rules as its $1.44 billion merger with American Axle & Manufacturing progresses toward a Q1 2026 close. Recent filings highlight positions exceeding 2% and daily dealings in ordinary shares, signaling active interest amid antitrust clearances and stock highs.
Dowlais Group plc Form 8.5 Disclosures Update
Recent regulatory filings under Form 8.5 (EPT/RI) and (EPT/NON-RI) have shed light on the positions and trading activities of major exempt principal traders in Dowlais Group plc shares. These disclosures are mandated by the UK Takeover Code due to the company’s ongoing offer period stemming from the proposed combination with U.S.-based American Axle & Manufacturing Holdings, Inc.
Barclays Capital Securities Ltd, a key market participant connected to Dowlais, reported dealings on January 6, 2026. The firm purchased 285,491 ordinary shares at prices ranging from 0.8328 GBP to 0.8575 GBP per share, while selling 278,277 shares within the same price band. Following these transactions, Barclays holds interests in 35,433,007 shares (2.69% of relevant securities) and short positions in 36,229,219 shares (2.74%). This includes cash-settled derivatives, with notable swap and CFD adjustments reflecting both increasing and decreasing short positions.
In a separate filing for January 5, 2026, Barclays disclosed similar activity: purchases of 373,453 shares and sales of 453,162 shares, with prices between 0.8395 GBP and 0.8505 GBP. Post-dealing positions stood at 35,295,651 long (2.68%) and 35,985,840 short (2.73%), incorporating derivative adjustments.
Investec Bank plc, acting as broker to Dowlais, detailed dealings on January 6, 2026, involving purchases of 191,762 ordinary shares at 84 GBP to 84.9 GBP and sales of 237,087 shares at 84 GBP to 84.35 GBP. No derivative transactions or other dealings were reported in this instance.
These activities occur against a backdrop of Dowlais shares reaching a 52-week high of 88.70 GBp (approximately $1.20 USD at current exchange rates), with recent trading volumes surpassing 17 million shares. The stock’s upward trajectory aligns with positive merger developments, including unconditional clearances from antitrust authorities in the EU, U.S., UK, and other jurisdictions.
Key Positions and Implications
Ownership Thresholds : Positions above 1% trigger disclosures, providing transparency into potential influences on share price during the offer period.
Derivative Exposure : Cash-settled swaps and CFDs indicate hedging strategies, with Barclays showing balanced long and short adjustments to manage risk.
Market Dynamics : The dealings reflect liquidity provision by exempt traders, potentially stabilizing volatility as the merger nears completion.
Merger Context and Strategic Fit
| Disclosing Party | Date of Dealing | Purchases (Shares) | Sales (Shares) | Price Range (GBP) | Total Interests (%) | Total Short Positions (%) |
|---|---|---|---|---|---|---|
| Barclays Capital Securities Ltd | Jan 6, 2026 | 285,491 | 278,277 | 0.8328 – 0.8575 | 2.69 | 2.74 |
| Barclays Capital Securities Ltd | Jan 5, 2026 | 373,453 | 453,162 | 0.8395 – 0.8505 | 2.68 | 2.73 |
| Investec Bank plc | Jan 6, 2026 | 191,762 | 237,087 | 84 – 84.9 | N/A | N/A |
The proposed cash-and-share deal values Dowlais at around GBP 1.16 billion ($1.56 billion USD), combining AAM’s driveline expertise with Dowlais’ powder metallurgy and automotive components divisions. With seven of ten required antitrust approvals secured, the transaction positions the merged entity to capitalize on electrification trends in the global auto sector. Dowlais’ 2024 adjusted revenue of GBP 4.937 billion and operating profit of GBP 324 million underscore its appeal as an acquisition target.
Investors monitoring these disclosures should note the absence of indemnity arrangements or option-related agreements in the filings, suggesting straightforward market-making activities without additional complexities.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any securities. All data is derived from publicly available regulatory filings and market reports. Readers should conduct their own research and consult qualified professionals before making investment decisions.